Noteworthy new reports from the Congressional Research Service that have not been made readily to the public include the following (all pdf).
“North Korea: Legislative Basis for U.S. Economic Sanctions,” September 29, 2010.
“China’s Sovereign Wealth Fund: Developments and Policy Implications,” September 23, 2010.
“Defense: FY2011 Authorization and Appropriations,” September 17, 2010.
“Federal Conspiracy Law: A Brief Overview,” April 30, 2010.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.